Danny Shih
Impact in
-
- Drug Solubulity and Delivery Systems
-
- PARP inhibition in cancer therapy
- Lung Cancer Research Studies
Papers in
- Oncology 6
- PARP inhibition in cancer therapy 3
- HER2/EGFR in Cancer Research 2
- Colorectal Cancer Treatments and Studies 2
-
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Darrin Despain (2 shared papers)Silvia Novello (2 shared papers)Wallace Akerley (1 shared paper)Lyudmila Bazhenova (2 shared papers)Laura DeForge (1 shared paper)Collin M. Blakely (2 shared papers)David Russell (1 shared paper)Paroma Chakravarty (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)ESMO Open (1 paper)Journal of Pharmaceutical Sciences (1 paper)Journal of Immunological Methods (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Danny Shih
7 papers receiving 49 citations
Peers
Comparison fields: 5 of 28
- Pharmaceutical Science 7
- Oncology 16
- Reproductive Medicine 5
- Pulmonary and Respiratory Medicine 16
- Biomaterials 4
Countries citing papers authored by Danny Shih
This map shows the geographic impact of Danny Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny Shih more than expected).
Fields of papers citing papers by Danny Shih
This network shows the impact of papers produced by Danny Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny Shih. The network helps show where Danny Shih may publish in the future.
Co-authors
The 25 scholars most cited alongside Danny Shih, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 19 | |
| 2 | 2019 | 13 | |
| 3 | 2007 | 8 | |
| 4 | 2024 | 5 | |
| 5 | 2017 | 2 | |
| 6 | 2019 | 2 | |
| 7 | 2024 | 1 |
About Danny Shih
Danny Shih is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Reproductive Medicine, Immunology and Molecular Biology, having authored 7 papers that have together received 50 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (3 papers), PARP inhibition in cancer therapy (3 papers), Lung Cancer Treatments and Mutations (2 papers), HER2/EGFR in Cancer Research (2 papers), Colorectal Cancer Treatments and Studies (2 papers), interferon and immune responses (1 paper), Pharmacological Effects of Natural Compounds (1 paper) and NF-κB Signaling Pathways (1 paper). The work is most often cited by research in Pharmaceutical Science (7 citations), Oncology (16 citations), Reproductive Medicine (5 citations), Pulmonary and Respiratory Medicine (16 citations) and Biomaterials (4 citations). Danny Shih has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Darrin Despain, Silvia Novello, Wallace Akerley, Lyudmila Bazhenova, Laura DeForge, Collin M. Blakely, David Russell, Paroma Chakravarty, Sanjay Popat and Patricia Siguenza. Their work appears in journals such as Journal of Clinical Oncology, ESMO Open, Journal of Pharmaceutical Sciences, Journal of Immunological Methods and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.